The taxoids: paclitaxel and docetaxel

The Lancet

Volumn 344, Issue 8932, 1994, Pages 1267-1272

  Gelmon, K ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; CIMETIDINE; DEXAMETHASONE; DIPHENHYDRAMINE; DOCETAXEL; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL; STEROID;

ALOPECIA; ANEMIA; ANGIONEUROTIC EDEMA; ANXIETY; BREAST CANCER; BRONCHOSPASM; CANCER; CANCER RECURRENCE; CHEMICAL STRUCTURE; CLINICAL TRIAL; CYTOTOXICITY; DESQUAMATION; FEVER; FLUSHING; GASTROINTESTINAL SYMPTOM; HEAD AND NECK CANCER; HUMAN; HYPERSENSITIVITY REACTION; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MELANOMA; META ANALYSIS; MUCOSA INFLAMMATION; NEUTROPENIA; ONYCHOLYSIS; OVARY CARCINOMA; PREMEDICATION; PRIORITY JOURNAL; PRURITUS; RASH; RESPIRATORY ARREST; REVIEW; STOMACH CANCER; THROMBOCYTOPENIA; WEIGHT GAIN;

EID: 0027942353     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)90754-4     Document Type: Article

References (39)

1. Plant antitumour agents VI. The isolation and structure of taxol: a novel antileukemic and antitumour agent from Taxus brevifolia.
2. Promotion of microtubule assembly in vitro by taxol
3. Experimental properties of RP 56976, a taxol derivative
4. Experimental antitumour activity of Taxotere (RP 56976, NSC 628503) a taxol analogue
5. Mechanism of action of Taxol
6. Differential effects of taxol or Taxotere on Tau and MAP2 containing microtubules
7. Taxol sensitizes human astrocytoma cell to radiation
8. Biosynthesis of heterogeneous forms of multidrug resistance-associated glycoproteins
9. Taxol-requiring mutant of Chinese hamster ovary cells with impaired mitotic spindle assembly
10. Cytotoxic studies of paclitaxel (TAXOL) in human tumour cell lines
11. Pharmacokinetics of paclitaxel and metabolites in a randomised comparative study in platimum pretreated ovarian cancer patients
12. Phase 1 and pharmacokinetic study of RP 569976 in a new ethanol-free formulation of Taxotere
13. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms
14. Taxol in relapsed ovarian cancer: high vs low dose and short vs long infusion
15. Phase 1 trial of intraperitoneal taxol: a gynecologic oncology group study
16. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer
17. Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony stimulating factor in the treatment of breast cancer
18. Randomised trial of two doses of paclitaxel in metastatic breast cancer after failure of standard therapy
19. Phase I/II study of taxol 96 hour infusion in refractory lymphoma and breast cancer; pharmacodynamics and analysis of multidrug resistance
20. Phase 22 study of taxol, merbarone, and piroxantrone in stage IV non small cell lung cancer: the Eastern Cooperative Oncology Group results
21. Phase II study of taxol in patients with untreated advanced non small cell lung cancer
22. Phase II study of Taxol in patients with extensive stage small cell lung cancer (SCLC): an Eastern Cooperative Oncology Group Study
23. Phase II evaluation of taxol in advanced head and neck cancer: an eastern cooperative oncology group trial
24. Phase I/II study of taxol 96 hour infusion in refractory lymphoma and breast cancer: pharmacodynamics and analysis of multidrug resistance
25. Taxol in malignant melanoma
26. Phase 2 study of Taxotere in ovarian cancer
27. Taxotere: an active new drug for the treatment of advanced ovarian carcinoma
28. Phase 2 study of Taxotere as first line chemotherapy for metastatic breast cancer
29. Preliminary report of a phase II study of docetaxel (taxotere) for recurrent or metastatic non-small cell lung cancer (NSCLC)
30. Recent clinical developments and future directions with docetaxel
31. Overview of taxol safety
32. Reassessment of cardiac toxicity associated with Taxol
33. Predictors and treatment of docetaxel toxic effects
34. Schedule dependent pharmacokinetics in a phase I trial of Taxol and doxorubicin as initial chemotherapy for metastatic breast cancer
35. A phase I study of Taxol, doxorubicin plus granulocyte colony stimulating factor in pateints with metastatic breast cancer
36. Pilot trial of alternating Taxol and adriamycin for metastatic breast cancer